Efficacy and safety of lamivudine treatment in late pregnancy with high HBV DNA: a perspective for mother and infants
Introduction: Perinatal transmission - from mother to fetus - is one of the main transmission routes of chronic hepatitis B (CHB) infection. Lamivudine therapy has been reported to prevent the replication of hepatitis B virus (HBV) in pregnant women with a high viral load that can lead to perinatal...
Saved in:
| Main Authors: | Sükran Köse, Melda Türken, İlker Devrim, Cüneyt Taner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2011-03-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/1398 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
by: Alfredo Marzano
Published: (2009-11-01) -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
by: Alfredo Marzano
Published: (2009-11-01) -
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
by: Jurgen Gerada, et al.
Published: (2013-06-01) -
Treatment of subacute hepatitis B with lamivudine: A pilot study in Serbia
by: Delić Dragan, et al.
Published: (2009-01-01) -
Successful lamivudine therapy for chronic hepatitis B in the family
by: Nožić Darko
Published: (2006-01-01)